Stay updated with breaking news from Michaelj Blaha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New analysis of the REDUCE-IT trial suggested benefit of icosapent ethyl doesn't vary by Lp(a) level and confirmed risk for Lp(a) with high triglycerides but not cholesterol.
A new diagnosis of type 2 diabetes is associated with increased 10-year risk of cardiovascular disease in both sexes and across all age groups, but particularly in those younger than 40, research shows.
The data are a call to action to treat young diabetic patients more aggressively with CVD-reduction strategies, says Michael Blaha.
Michael J. Blaha, MD, MPH, discusses his interpretation of the growing data detailing the role of inflammation as a driver of cardiovascular risk and how clinicians can identify patients who stand to benefit most from colchicine 0.5 mg tablets.
According to a recent study published in the Journal of the American Heart Association, individuals who suffered from depression during pregnancy were found to have a higher likelihood of being diagnosed with cardiovascular disease within two years post-partum. A study of more than 100,000 peop